✦ LIBER ✦

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects

✍ Scribed by Letendre, S. L.; Mills, A. M.; Tashima, K. T.; Thomas, D. A.; Min, S. S.; Chen, S.; Song, I. H.; Piscitelli, S. C.

Book ID: 125483394
Publisher: University of Chicago Press
Year: 2014
Tongue: English
Weight: 328 KB
Volume: 59
Category: Article
ISSN: 1058-4838
DOI: 10.1093/cid/ciu477

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multinational study of neurological pe

A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

✍ Kevin Robertson; Johnstone Kumwenda; Khuanchai Supparatpinyo; Jeanne H. Jiang; S 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 169 KB

Hyperlactataemia in HIV-infected subject

Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)

✍ ER Feeney; C Chazallon; N O'Brien; V Meiffrédy; RL Goodall; J-P Aboulker; DA Coo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

Antiviral activity and safety of aplavir

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136)

✍ P Yeni; A LaMarca; D Berger; P Cimoch; A Lazzarin; P Salvato; FM Smaill; E Teofi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Phase 2a Randomized Controlled Trial of

Phase 2a Randomized Controlled Trial of Short-Term Activity, Safety, and Pharmacokinetics of a Novel Nonnucleoside Reverse Transcriptase Inhibitor, RDEA806, in HIV-1-Positive, Antiretroviral-Naive Subjects

✍ Moyle, G.; Boffito, M.; Stoehr, A.; Rieger, A.; Shen, Z.; Manhard, K.; Sheedy, B 📂 Article 📅 2010 🏛 American Society for Microbiology 🌐 English ⚖ 618 KB

The AmRo study: pregnancy outcome in HIV

The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery

✍ K Boer; JF Nellen; D Patel; S Timmermans; C Tempelman; M Wibaut; MA Sluman; ME V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Phase I/II study of the pharmacokinetics

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults

✍ Markowitz, M.; Zolopa, A.; Squires, K.; Ruane, P.; Coakley, D.; Kearney, B.; Zho 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 393 KB